NASDAQ:OFIX Orthofix Medical (OFIX) Stock Price, News & Analysis $16.51 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$16.21▼$16.9250-Day Range$12.38▼$16.9352-Week Range$9.57▼$21.60Volume242,940 shsAverage Volume361,256 shsMarket Capitalization$619.62 millionP/E RatioN/ADividend YieldN/APrice Target$18.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Orthofix Medical alerts: Email Address Orthofix Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside9.0% Upside$18.00 Price TargetShort InterestBearish11.27% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.24Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.72) to ($0.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.33 out of 5 starsMedical Sector910th out of 936 stocksSurgical & Medical Instruments Industry99th out of 101 stocks 1.2 Analyst's Opinion Consensus RatingOrthofix Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageOrthofix Medical has only been the subject of 2 research reports in the past 90 days.Read more about Orthofix Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.27% of the outstanding shares of Orthofix Medical have been sold short.Short Interest Ratio / Days to CoverOrthofix Medical has a short interest ratio ("days to cover") of 13.7, which indicates bearish sentiment.Change versus previous monthShort interest in Orthofix Medical has recently decreased by 4.73%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldOrthofix Medical does not currently pay a dividend.Dividend GrowthOrthofix Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OFIX. Previous Next 2.9 News and Social Media Coverage News SentimentOrthofix Medical has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Orthofix Medical this week, compared to 3 articles on an average week.Search Interest1 people have searched for OFIX on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Orthofix Medical to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Orthofix Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.70% of the stock of Orthofix Medical is held by insiders.Percentage Held by Institutions89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Orthofix Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Orthofix Medical are expected to grow in the coming year, from ($1.72) to ($0.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Orthofix Medical is -4.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Orthofix Medical is -4.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthofix Medical has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Orthofix Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. About Orthofix Medical Stock (NASDAQ:OFIX)Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.Read More OFIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OFIX Stock News HeadlinesJuly 26 at 1:12 AM | americanbankingnews.comAnalysts Set Orthofix Medical Inc. (NASDAQ:OFIX) Price Target at $18.00July 20, 2024 | americanbankingnews.comResearch Analysts Issue Forecasts for Orthofix Medical Inc.'s Q3 2024 Earnings (NASDAQ:OFIX)July 26, 2024 | Crypto 101 Media (Ad)Brace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.July 16, 2024 | prnewswire.comOFIX The Schall Law Firm is Investigating Claims Against Orthofix Medical Inc.July 9, 2024 | prnewswire.comOFIX The Schall Law Firm is Investigating Claims Against Orthofix Medical Inc.June 24, 2024 | businesswire.comMichael Finegan Named Chair of the Orthofix Board of DirectorsJune 18, 2024 | businesswire.comAviva McPherron Joins Orthofix as President of Global Operations and QualityJune 11, 2024 | businesswire.comOrthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global SpineJuly 26, 2024 | Crypto 101 Media (Ad)Brace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.May 23, 2024 | businesswire.comOrthofix Names Max Reinhardt President of Global Spine BusinessMay 16, 2024 | businesswire.comOrthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards ProgramMay 9, 2024 | msn.comRoth MKM Upgrades Orthofix Medical (OFIX)May 9, 2024 | msn.comOrthofix gets FDA clearance for Rodeo Telescopic NailMay 9, 2024 | finance.yahoo.comOrthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic NailMay 8, 2024 | msn.comRoth MKM ups Orthofix to buy, cites improving fundamentalsMay 8, 2024 | finance.yahoo.comOrthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comOrthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...May 7, 2024 | investorplace.comOFIX Stock Earnings: Orthofix Medical Meets EPS, Beats Revenue for Q1 2024See More Headlines Receive OFIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:OFIX CUSIPN6748L10 CIK884624 Webwww.orthofix.com Phone(214) 937-2000Fax599 9 461 6978Employees1,634Year Founded1980Price Target and Rating Average Stock Price Target$18.00 High Stock Price Target$20.00 Low Stock Price Target$16.00 Potential Upside/Downside+9.0%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-151,400,000.00 Net Margins-16.64% Pretax Margin-16.25% Return on Equity-14.24% Return on Assets-9.49% Debt Debt-to-Equity Ratio0.23 Current Ratio2.65 Quick Ratio1.19 Sales & Book Value Annual Sales$746.64 million Price / Sales0.83 Cash FlowN/A Price / Cash FlowN/A Book Value$16.11 per share Price / Book1.02Miscellaneous Outstanding Shares37,530,000Free Float35,765,000Market Cap$619.62 million OptionableOptionable Beta1.05 Social Links 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Kimberley A. Elting (Age 59)President of Global Orthopedics Comp: $766.67kMs. Julie B. Andrews (Age 53)Chief Financial Officer Mr. Roberto DonadelloSenior Vice President of Global OperationsMr. Dan E. YarbroughVice President of Investor RelationsMs. Jill MasonInterim Chief Ethics & Compliance Officer and VP of Corporate CounselMr. Ehab M. Esmail (Age 52)Senior Vice President of Global Quality, Regulatory & Clinical Affairs Mr. Tyler P. Lipschultz (Age 57)President of Global Biologics Dr. Beau Standish P.Eng. (Age 43)Ph.D., President of Global Enabling Technologies Mr. Geoffrey C. GillespieVP & Corporate ControllerMore ExecutivesKey CompetitorsAnika TherapeuticsNASDAQ:ANIKIntersect ENTNASDAQ:XENTVapothermNYSE:VAPOAlphatecNASDAQ:ATECAtriCureNASDAQ:ATRCView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 9,118 shares on 7/26/2024Ownership: 0.383%SG Americas Securities LLCSold 7,273 shares on 7/12/2024Ownership: 0.026%Jacobs Levy Equity Management Inc.Sold 255,053 shares on 5/16/2024Ownership: 1.046%California State Teachers Retirement SystemSold 5,255 shares on 5/16/2024Ownership: 0.089%Price T Rowe Associates Inc. MDBought 1,236 shares on 5/15/2024Ownership: 0.088%View All Insider TransactionsView All Institutional Transactions OFIX Stock Analysis - Frequently Asked Questions How have OFIX shares performed this year? Orthofix Medical's stock was trading at $13.48 at the start of the year. Since then, OFIX stock has increased by 22.5% and is now trading at $16.51. View the best growth stocks for 2024 here. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc. (NASDAQ:OFIX) issued its quarterly earnings results on Tuesday, May, 7th. The medical device company reported ($0.95) EPS for the quarter, missing analysts' consensus estimates of ($0.54) by $0.41. The medical device company had revenue of $188.61 million for the quarter, compared to analyst estimates of $183.40 million. Orthofix Medical had a negative net margin of 16.64% and a negative trailing twelve-month return on equity of 14.24%. What is Brad Mason's approval rating as Orthofix Medical's CEO? 32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees. Who are Orthofix Medical's major shareholders? Orthofix Medical's top institutional investors include Bank of New York Mellon Corp (0.38%) and SG Americas Securities LLC (0.03%). Insiders that own company stock include Kevin J Kenny, Shweta Maniar, Jon Carl Serbousek, Michael E Paolucci, Kimberley A Elting, Catherine M Burzik and Rice Doug. View institutional ownership trends. How do I buy shares of Orthofix Medical? Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE) and Exxon Mobil (XOM). This page (NASDAQ:OFIX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthofix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.